Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
出版年份 2016 全文链接
标题
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 23, Issue 12, Pages R551-R566
出版商
Bioscientifica
发表日期
2016-10-04
DOI
10.1530/erc-16-0151
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of the efficacy and the safety of lanreotide autogel 120 mg on tumor growth stabilization in patients with progressive neuroendocrine tumors (NETs) who are not eligible to surgery or chemotherapy.
- (2017) M. Martin-Richard et al. JOURNAL OF CLINICAL ONCOLOGY
- Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
- (2016) Jakob Dal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Patchwork
- (2016) Mary M.W. Billington JOURNAL OF CLINICAL ONCOLOGY
- Octreotide LAR: safety and tolerability issues
- (2016) Jan Bornschein et al. Expert Opinion On Drug Safety
- Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
- (2015) Fredrik Tiberg et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo armpost hocanalysis
- (2015) Jonathan R Strosberg et al. ENDOCRINE-RELATED CANCER
- Mortality in acromegaly: a 20-year follow-up study
- (2015) Elina Ritvonen et al. ENDOCRINE-RELATED CANCER
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- (2015) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly
- (2015) Andrew S. Powlson et al. NEUROENDOCRINOLOGY
- Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study
- (2015) Philippe J. Caron et al. Pituitary
- Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Drug delivery applications of non-lamellar liquid crystalline phases and nanoparticles
- (2015) F. Tiberg et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial
- (2014) S L Fougner et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
- (2014) E. Ghigo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression
- (2013) Leandro Kasuki et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
- (2013) Laurence Katznelson et al. Endocrine Practice
- Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours
- (2013) A. Romer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned
- (2013) J. C. Yao et al. ONCOLOGIST
- Biochemical and quality of life responses to octreotide-LAR in acromegaly
- (2013) Ruth Mangupli et al. Pituitary
- Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly
- (2013) Juan Francisco Martín-Rodríguez et al. PLoS One
- Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis
- (2013) Francisco Pita-Gutierrez et al. PLoS One
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) K. Oberg et al. ANNALS OF ONCOLOGY
- Phase Behavior, Functions, and Medical Applications of Soy Phosphatidylcholine and Diglyceride Lipid Compositions
- (2012) Fredrik Tiberg et al. CHEMISTRY LETTERS
- Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers: A Single-Center, Open-Label, Ascending-Dose Study
- (2012) Stephan Petersenn et al. CLINICAL THERAPEUTICS
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
- (2012) Larry K Kvols et al. ENDOCRINE-RELATED CANCER
- Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study
- (2012) H. Dietrich et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Lutetium-labelled peptides for therapy of neuroendocrine tumours
- (2012) B. L. R. Kam et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
- (2012) Linda Villard et al. JOURNAL OF CLINICAL ONCOLOGY
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor Effects of Somatostatin Analogs in Neuroendocrine Tumors
- (2012) L. Sideris et al. ONCOLOGIST
- Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
- (2012) Andrea Giustina et al. PLoS One
- Novel pathway for somatostatin analogs in patients with acromegaly
- (2012) Mônica R. Gadelha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
- (2011) Claudia Ramírez et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
- (2011) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pasireotide (SOM230), a Novel Multireceptor-Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7-Day Subcutaneous Infusion in Healthy Male Volunteers
- (2011) Stephan Petersenn et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of somatostatin analogs on glucose homeostasis in rats
- (2011) Herbert A Schmid et al. JOURNAL OF ENDOCRINOLOGY
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical, quality of life, and economic value of acromegaly disease control
- (2011) A. Ben-Shlomo et al. Pituitary
- Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy
- (2010) Su-Jung Kim et al. BMC CANCER
- Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study
- (2010) Ming Shen et al. ENDOCRINE JOURNAL
- Mortality in Patients with Pituitary Disease
- (2010) Mark Sherlock et al. ENDOCRINE REVIEWS
- Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial
- (2010) Zhi-gang Mao et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Endocrine Aspects of Obstructive Sleep Apnea
- (2010) Pierre Attal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence of Cognitive and Neurophysiological Impairment in Patients with Untreated Naive Acromegaly
- (2010) José Leon-Carrion et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Elucidation of the Self-Assembly Pathway of Lanreotide Octapeptide into β-Sheet Nanotubes: Role of Two Stable Intermediates
- (2010) Emilie Pouget et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs)
- (2010) Lowell B. Anthony et al. PANCREAS
- The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
- (2010) J. Philip Boudreaux et al. PANCREAS
- Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review
- (2010) Maria Fleseriu Pituitary
- A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
- (2009) Peter J. Trainer et al. CLINICAL ENDOCRINOLOGY
- Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients
- (2009) Caroline Sievers et al. CLINICAL ENDOCRINOLOGY
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
- (2008) T. R. Halfdanarson et al. ANNALS OF ONCOLOGY
- Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas
- (2008) Agatha A. van der Klaauw et al. CLINICAL ENDOCRINOLOGY
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance
- (2008) Maria P Matta et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls
- (2008) C Sievers et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
- (2008) Robert D. Murray et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Divergence between Growth Hormone and Insulin-Like Growth Factor-I Concentrations in the Follow-Up of Acromegaly
- (2008) Orsalia Alexopoulou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial
- (2008) Sven M. Carlsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Somatostatin AnalogsVersusSurgery on Glucose Metabolism in Acromegaly: Results of a 5-Year Observational, Open, Prospective Study
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
- (2008) Theodoros Rokkas et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide (SOM230): Development, mechanism of action and potential applications
- (2007) Herbert A. Schmid MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now